Edward J. Dulac III
2020
In 2020, Edward J. Dulac III earned a total compensation of $5.7M as Chief Financial Officer at Fate Therapeutics.
Compensation breakdown
| Bonus | $137,917 |
|---|---|
| Non-Equity Incentive Plan | $75,833 |
| Option Awards | $3,786,529 |
| Salary | $142,500 |
| Stock Awards | $1,420,800 |
| Other | $120,000 |
| Total | $5,683,579 |
Dulac received $3.8M in option awards, accounting for 67% of the total pay in 2020.
Dulac also received $137.9K in bonus, $75.8K in non-equity incentive plan, $142.5K in salary, $1.4M in stock awards and $120K in other compensation.
Rankings
In 2020, Edward J. Dulac III's compensation ranked 1,885th out of 13,090 executives tracked by ExecPay. In other words, Dulac earned more than 85.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,885 out of 13,090 | 86th |
Division Manufacturing | 734 out of 5,620 | 87th |
Major group Chemicals And Allied Products | 264 out of 2,253 | 88th |
Industry group Drugs | 222 out of 1,953 | 89th |
Industry Biological Products, Except Diagnostic Substances | 64 out of 411 | 84th |
Source: SEC filing on April 21, 2021.
Dulac's colleagues
We found four more compensation records of executives who worked with Edward J. Dulac III at Fate Therapeutics in 2020.